Common Stock and Stock Options | Note 4. Common Stock and Stock Options Stock Based Compensation cost for all stock awards is based on the grant date fair value and recognized over the required service (vesting) period. Non cash stock-based compensation expense was $8,670 and $31,182 for the three months ended September 30, 2021, and 2020, respectively. Noncash stock-based compensation expense was $39,233 and $93,544 for the nine months ended September 30, 2021, and 2020, respectively. Unrecognized compensation expense was $7,487 as of September 30, 2021, and will be recognized through 2023. There was no tax benefit recorded for this compensation cost as the expense primarily relates to incentive stock options that do not qualify for a tax deduction until, and only if, a qualifying disposition occurs. The non-employee Board members received compensation of 7,605 and 75,475 aggregate shares of common stock of the Company during the nine months ended September 30, 2021, and 2020, respectively. The stock had an aggregate value of $22,475 and $89,998 for the nine months ended September 30, 2021, and 2020, respectively, and was recorded as non-cash stock compensation expense in the financial statements. Employees received compensation of 4,804 aggregate shares of common stock of the Company during the nine months ended September 30, 2021, which had an aggregate value of $13,211, and was recorded as noncash stock-based compensation expense in the financial statements. In addition, during the nine months ended September 30, 2021, a total of 30,181 stock options were exercised by management. Note 4. Common Stock and Stock Options (continued) The cumulative status of options granted and outstanding at September 30, 2021, and December 31, 2020, as well as options which became exercisable in connection with the Company’s stock option plans is summarized as follows: Weighted Average Stock Options Exercise Price Outstanding at January 1, 2020 76,037 $ 1.03 Outstanding at December 31, 2020 76,037 $ 1.03 Exercised (30,181) 0.96 Outstanding at September 30, 2021 45,856 $ 1.07 Options exercisable at December 31, 2020 55,208 $ 0.94 Options exercisable at September 30, 2021 31,970 $ 0.99 Exercise prices for options ranged from $0.84 to $1.25 at September 30, 2021. The weighted average option price for all options outstanding at September 30, 2021, was $1.07 with a weighted average remaining contractual life of 5.0 years. |